Investigators from the C.S. Mott Center for Human Growth and Development at the Wayne State University School of Medicine reported today in Cancer Immunology Research the characterization of a novel therapeutic approach capable ...
Dec 11, 2023
0
5
A person's immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure—and differences in the focus of immune responses will help scientists understand how to optimize vaccines ...
Oct 5, 2023
1
9
The number of new coronavirus cases fell everywhere in the world last week by about 12%, according to the World Health Organization's latest weekly review of the pandemic issued Wednesday.
Sep 7, 2022
0
13
For most people, poliomyelitis (polio) is a threat of the past.
Jul 7, 2022
0
7
The innate immune system plays a crucial role in regulating host-microbe interactions, and especially in providing protection against pathogens that invade the mucosa. Using an intestinal infection model, scientists from ...
Feb 28, 2022
0
397
A novel form of macrophage-based immunotherapy is effective at treating a broad spectrum of cancers, including those at advanced stages, according to a groundbreaking study led by Georgia State immunology professor Yuan Liu.
May 31, 2021
0
40
White blood cells are known to circulate through the entire body through blood vessels, acting as a surveillance system. However, a specialized group of these cells are permanently present in tissues like the skin, intestine ...
May 18, 2020
0
123
Men who are diagnosed with low-risk prostate cancer usually opt for active surveillance—a monitoring of their cancer over time without undergoing treatments that would cause side effects. In many men, the cancer never grows ...
Sep 20, 2019
0
3
Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma (GBM) progression by shutting down immune surveillance, indicating a potential new ...
Jan 25, 2019
0
37
Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.
Nov 8, 2017
0
534
